MiekeVHR · 6 years ago
Still a lot to be defined in terms of treating #prostatecancer patients with oligo metastasis. Interesting debate at #EAU19 @AlbertoBossial @ABrigantiMD @TOUR_KCL. What do we do #UroSoMe? https://t.co/mhLoEJwe03
Still a lot to be defined in terms of treating #prostatecancer patients with oligo metastasis. Interesting debate at #EAU19 @AlbertoBossial @ABrigantiMD @TOUR_KCL. What do we do #UroSoMe? https://t.co/mhLoEJwe03
#UroLift System #EAU19 #minimallyinvasive #urology https://t.co/Px9OvCwgEa
Great debate about the role of local therapy for oligometastasis prostate cancer… #EAU19 @Uroweb @AFUrologie @afufuro https://t.co/qhfWDfWDn9
RAKT update from the ERUS-RAKT group. Selected as one of the best posters in the session congratulations to all group @AlbertoBreda1 @Ric_Campi @KarelDecaestec1 @mireiamusquera #EAU19 @ERUSrobotics @Uroweb https://t.co/hwhhNDG7nX
Satisfaction and confidence with surgical training among European trainees: 25-30 % of senior residents are confident with their training and 86% think they DO NOT perform enough surgeries #EAU19 #visualabstract @ESRUrology @eau_yuo https://t.co/aj3KDPeIdy
Big leaps forward in #fertility preservation in boys undergoing #cancer treatments awaited over the next years. Imagine saving and reimplanting healthy testicular tissue after chemotherapy/radiation. Overview by @CFuglesangSJ at #EAU19 @JSnksen @MaartenAlbersen @Uroweb https://t.co/BS5Jtk3TTt
Fertility and sexual issues in cancer survivors seems not to be a sexy topic #EAU19 https://t.co/euwRvJWZT2
#TreatBPH #EAU19 https://t.co/yFbtZnshvt
Aleksander Giwercman concludes that hypogonadism in testicular cancer survivors is a riskfactor for morbidity. TRT is underused but question remains if TRT will alleviate CV risks #EAU19 @CFuglesangSJ @MaartenAlbersen @MikkelFode https://t.co/HccBRQjznw
#EAU19 use your opponent to talk #StoneSmart and #TreatBPH – here for you https://t.co/IYQdKDe8FI
In European Urology Today right je – the urological Social Media read for your flight home.
#urosome #eau19 https://t.co/D8VNo1aewK
Very (very!) interesting new data from @SaveYourSexLife at #EAU19: Only 1 PSA recurrence over a median of 38 mth in 360 men receiving #testosterone therapy following #ProstateCancer surgery @MaartenAlbersen @JSnksen @jsexmed @Uroweb @EUplatinum @NatRevUrol @yoursexmedjour https://t.co/5m8MNarm3S